CORUM PHARMA

Wielsbeke ·KBO/BCE: BE 0763.652.492

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-03-2025	31-10-2025	31-10-2025	on the day	2025-00560253
31-03-2024	31-10-2024	28-10-2024	3 d early	2024-00516329
31-03-2023	31-10-2023	30-10-2023	1 d early	2023-00501783
31-03-2022	31-10-2022	03-11-2022	3 d late	2022-20483200

Metric	This company	Sector median	Position in the sector
Solvency	71.5%	43.2%	better than 75% of 498 sector peers
Net result	€72k	€68k	better than 51% of 498 sector peers
Equity	€1.67M	€492k	better than 76% of 498 sector peers
Gross operating margin	€112k	€83k	better than 61% of 497 sector peers
Total assets	€2.34M	€1.58M	better than 63% of 498 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€2.34M
Fixed assets	21/28	€2.30M
Tangible fixed assets	22/27	€39k
Financial fixed assets	28	€2.26M
Current assets	29/58	€35k
Amounts receivable within one year	40/41	€13k
Investments	50/53	€22k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€2.34M
Equity	10/15	€1.67M
Contributions / capital	10/11	€50k
Reserves	13	€1.62M
Amounts payable	17/49	€664k
Amounts payable after one year	17	€466k
Amounts payable within one year	42/48	€196k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€112k
Operating result	9901	€99k
Financial charges	65	€6k
Result before taxes	9903	€93k
Income taxes	67/77	€21k
Net result for the period	9904	€72k
Result to be appropriated	9905	€72k

Summary